The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation

New England Journal of Medicine

Volumn 341, Issue 11, 1999, Pages 801-806

  De Stefano, Valerio ^a   Martinelli, Ida ^b   Mannucci, Pier Mannuccio ^b   Paciaroni, Katia ^a   Chiusolo, Patrizia ^a   Casorelli, Ida ^a   Rossi, Elena ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADULT; AGED; ARTICLE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC LINKAGE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; DISEASE-FREE SURVIVAL; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POINT MUTATION; PROTHROMBIN; RECURRENCE; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0033539096     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199909093411104     Document Type: Article

References (27)

1. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
2. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 1998;24:367-79.
3. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden. Blood 1995;85: 1504-8.
4. Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 1995;92:2800-2.
5. 506→Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997;336:399-403.
6. Rintelen C, Pabinger I, Knobl P, Lechner K, Mannhalter C. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost 1996;75:229-32.
7. Eichinger S, Pabinger I, Stumpflen A, et al. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thromb Haemost 1997;77:624-8.
8. Lindmarker P, Schulman S, Sten-Linder M, et al. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. Thromb Haemost 1999;81:684-9.
9. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
10. Rosendaal FR, Doggen CJM, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79: 706-8.
11. Hillarp A, Zoller B, Svenson PJ, Dahlback B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997;78:990-2.
12. Leroyer C, Mercier B, Oger E, et al. Prevalence of the 20210 A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 1998;80:49-51.
13. 20210 gene variant. Ann Intern Med 1998;129:89-93.
14. De Stefano V, Chiusolo P, Paciaroni K, et al. Prevalence of the factor II G20210A mutation in symptomatic patients with inherited thrombophilia. Thromb Haemost 1998;80:342-3.
15. Ehrenforth S, Ludwig G, Klinke S, Krause M, Scharrer I, Nowak-Gottl U. The prothrombin 20210 A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia. Blood 1998;91:2209-10.
16. Zoller B, Svensson PJ, Dahlback B, Hillarp A. The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families. Blood 1998;91:2210-1.
17. Makris M, Preston FE, Beauchamp NJ, et al. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997;78:1426-9.
18. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996;87:3531-44.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
20. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986;105:429-35.
21. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
22. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia. Thromb Haemost 1996;76:824-34. [Erratum, Thromb Haemost 1997;77: 1047.]
23. Guidelines on oral anticoagulation: third edition. Br J Haematol 1998; 101:374-87.
24. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996;348:423-8.
25. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-7.
26. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hypcrhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997;95:1777-82.
27. Eichinger S, Minar E, Hirschl M, et al. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene. Thromb Haemost 1999; 81:14-7.